The European Investment Bank (EIB) and Angelini Ventures – Angelini Industries’ corporate venture capital fund – have signed an agreement to provide a total of €150 million in financing for European biotechnology and digital health startups. This is the first agreement the EIB has signed with a corporate venture capital in healthcare sector, and states that Angelini Ventures and the EIB will each invest €75 million over the next six years.
